Have your own idea? Try our Stock Screener
UPDATED Jan 22, 2025
Explore the U.S. (NYSE and NASDAQ) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.
Company | Last Price | 1D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
LLY | US$753.98 | 1.6% | 19.0% | US$668.4b | US$978.39 | PE81.1x | E24.8% | 0.8% | ||
SMMT | US$23.52 | 6.4% | 430.9% | US$16.3b | US$33.08 | PB39.6x | E38.9% | n/a | ||
MRNA | US$38.50 | 7.3% | -61.9% | US$13.8b | US$68.01 | PS2.9x | E23.7% | n/a | ||
NTRA | US$171.93 | 2.7% | 162.0% | US$22.1b | US$176.87 | PS14.8x | E55.6% | n/a | ||
TMO | US$574.59 | 0.3% | 6.4% | US$219.2b | US$645.22 | PE35.8x | E11.3% | 0.3% | ||
LEGN | US$37.44 | 8.0% | -37.7% | US$6.4b | US$79.83 | PS13.2x | E56.5% | n/a | ||
TEM | US$50.45 | 5.9% | n/a | US$7.5b | US$56.89 | PS12.4x | E37.9% | n/a | ||
MDGL | US$324.71 | 5.7% | 45.7% | US$6.7b | US$375.60 | PS92.2x | E59.9% | n/a | ||
ONC | US$222.22 | 1.6% | 38.3% | US$23.3b | US$283.39 | PS7.3x | E64.7% | n/a | ||
INSM | US$78.45 | 2.2% | 186.3% | US$13.7b | US$88.14 | PS40.9x | E55.3% | n/a | ||
AXSM | US$102.27 | 6.3% | 11.4% | US$4.7b | US$132.94 | PS14.6x | E57.8% | n/a | ||
BIIB | US$142.75 | 1.3% | -42.2% | US$20.5b | US$231.71 | PE12.9x | E10.3% | n/a | ||
RXRX | US$7.49 | 8.9% | -27.7% | US$2.7b | US$9.14 | PS45.3x | E-3.9% | n/a | ||
WST | US$347.87 | 0.9% | -0.2% | US$25.0b | US$379.85 | PE50.4x | E12.5% | 0.2% | ||
CRSP | US$44.20 | 6.5% | -29.9% | US$3.5b | US$84.08 | PS18.6x | E47.3% | n/a | ||
AVTR | US$22.10 | 1.5% | 0.1% | US$14.8b | US$26.48 | PE48.6x | E29.1% | n/a | ||
NUVL | US$81.32 | 3.9% | 6.2% | US$5.6b | US$115.08 | PB5.2x | E25.9% | n/a | ||
TEVA | US$22.01 | 0.9% | 83.9% | US$24.8b | US$24.95 | PS1.5x | E54.8% | 0% | ||
BGM | US$10.70 | 24.4% | n/a | US$836.1m | n/a | n/a | n/a | n/a | ||
ALNY | US$266.54 | 0.6% | 43.9% | US$34.2b | US$299.71 | PS16.4x | E56.7% | n/a | ||
BIO | US$360.54 | 1.9% | 13.9% | US$9.9b | US$404.33 | PS3.9x | E43.3% | n/a | ||
SRRK | US$46.73 | 4.1% | 217.0% | US$4.2b | US$48.75 | PB55.2x | E55.9% | n/a | ||
BHVN | US$40.56 | 3.9% | -11.1% | US$3.9b | US$65.29 | PB13x | E29.8% | n/a | ||
RARE | US$42.94 | 4.0% | -1.5% | US$3.8b | US$91.85 | PS7.6x | E56.3% | n/a |